 | • レポートコード：GIR-105X14210 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、遺伝子組換え型エリスロポエチン治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。遺伝子組換え型エリスロポエチン治療薬の種類別市場規模（rhEPO、赤血球生成刺激剤（ESA））、用途別市場規模（慢性腎臓病、がん関連貧血、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・遺伝子組換え型エリスロポエチン治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Amgen、Johnson & Johnson、Kyowa Hakko Kirin、Roche、3SBio Group、Celltrion, Inc、Teva Pharmaceutical Industries Ltd、F. Hoffmann-La Roche Ltd、LG Life Sciences Ltd、Biocon Limited、Intas Pharmaceuticals Ltd、Sun Pharmaceutical Industries Ltd、Dr. Reddy's Laboratories Ltd ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：rhEPO、赤血球生成刺激剤（ESA） ・用途別分析2016年-2026年：慢性腎臓病、がん関連貧血、その他 ・遺伝子組換え型エリスロポエチン治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・遺伝子組換え型エリスロポエチン治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・遺伝子組換え型エリスロポエチン治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・遺伝子組換え型エリスロポエチン治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・遺伝子組換え型エリスロポエチン治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Recombinant Erythropoietin Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Recombinant Erythropoietin Drugs size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Recombinant Erythropoietin Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Recombinant Erythropoietin Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
rhEPO
Erythropoiesis-Stimulating Agents (ESA)
Market segment by Application can be divided into
Chronic Kidney Disease
Cancer Related Anemia
Others
The key market players for global Recombinant Erythropoietin Drugs market are listed below:
Amgen
Johnson & Johnson
Kyowa Hakko Kirin
Roche
3SBio Group
Celltrion, Inc
Teva Pharmaceutical Industries Ltd
F. Hoffmann-La Roche Ltd
LG Life Sciences Ltd
Biocon Limited
Intas Pharmaceuticals Ltd
Sun Pharmaceutical Industries Ltd
Dr. Reddy’s Laboratories Ltd
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Recombinant Erythropoietin Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Recombinant Erythropoietin Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 rhEPO
1.2.3 Erythropoiesis-Stimulating Agents (ESA)
1.3 Market Analysis by Application
1.3.1 Overview: Global Recombinant Erythropoietin Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Chronic Kidney Disease
1.3.3 Cancer Related Anemia
1.3.4 Others
1.4 Global Recombinant Erythropoietin Drugs Market Size & Forecast
1.4.1 Global Recombinant Erythropoietin Drugs Sales in Value (2016-2026))
1.4.2 Global Recombinant Erythropoietin Drugs Sales in Volume (2016-2026)
1.4.3 Global Recombinant Erythropoietin Drugs Price by Type (2016-2026) & (USD/g)
1.5 Global Recombinant Erythropoietin Drugs Production Capacity Analysis
1.5.1 Global Recombinant Erythropoietin Drugs Total Production Capacity (2016-2026)
1.5.2 Global Recombinant Erythropoietin Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Recombinant Erythropoietin Drugs Market Drivers
1.6.2 Recombinant Erythropoietin Drugs Market Restraints
1.6.3 Recombinant Erythropoietin Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business
2.1.3 Amgen Recombinant Erythropoietin Drugs Product and Services
2.1.4 Amgen Recombinant Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Recombinant Erythropoietin Drugs Product and Services
2.2.4 Johnson & Johnson Recombinant Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Kyowa Hakko Kirin
2.3.1 Kyowa Hakko Kirin Details
2.3.2 Kyowa Hakko Kirin Major Business
2.3.3 Kyowa Hakko Kirin Recombinant Erythropoietin Drugs Product and Services
2.3.4 Kyowa Hakko Kirin Recombinant Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche Recombinant Erythropoietin Drugs Product and Services
2.4.4 Roche Recombinant Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 3SBio Group
2.5.1 3SBio Group Details
2.5.2 3SBio Group Major Business
2.5.3 3SBio Group Recombinant Erythropoietin Drugs Product and Services
2.5.4 3SBio Group Recombinant Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Celltrion, Inc
2.6.1 Celltrion, Inc Details
2.6.2 Celltrion, Inc Major Business
2.6.3 Celltrion, Inc Recombinant Erythropoietin Drugs Product and Services
2.6.4 Celltrion, Inc Recombinant Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Teva Pharmaceutical Industries Ltd
2.7.1 Teva Pharmaceutical Industries Ltd Details
2.7.2 Teva Pharmaceutical Industries Ltd Major Business
2.7.3 Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Product and Services
2.7.4 Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 F. Hoffmann-La Roche Ltd
2.8.1 F. Hoffmann-La Roche Ltd Details
2.8.2 F. Hoffmann-La Roche Ltd Major Business
2.8.3 F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Drugs Product and Services
2.8.4 F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 LG Life Sciences Ltd
2.9.1 LG Life Sciences Ltd Details
2.9.2 LG Life Sciences Ltd Major Business
2.9.3 LG Life Sciences Ltd Recombinant Erythropoietin Drugs Product and Services
2.9.4 LG Life Sciences Ltd Recombinant Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Biocon Limited
2.10.1 Biocon Limited Details
2.10.2 Biocon Limited Major Business
2.10.3 Biocon Limited Recombinant Erythropoietin Drugs Product and Services
2.10.4 Biocon Limited Recombinant Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Intas Pharmaceuticals Ltd
2.11.1 Intas Pharmaceuticals Ltd Details
2.11.2 Intas Pharmaceuticals Ltd Major Business
2.11.3 Intas Pharmaceuticals Ltd Recombinant Erythropoietin Drugs Product and Services
2.11.4 Intas Pharmaceuticals Ltd Recombinant Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Sun Pharmaceutical Industries Ltd
2.12.1 Sun Pharmaceutical Industries Ltd Details
2.12.2 Sun Pharmaceutical Industries Ltd Major Business
2.12.3 Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Product and Services
2.12.4 Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 Dr. Reddy’s Laboratories Ltd
2.13.1 Dr. Reddy’s Laboratories Ltd Details
2.13.2 Dr. Reddy’s Laboratories Ltd Major Business
2.13.3 Dr. Reddy’s Laboratories Ltd Recombinant Erythropoietin Drugs Product and Services
2.13.4 Dr. Reddy’s Laboratories Ltd Recombinant Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Recombinant Erythropoietin Drugs Sales by Manufacturer
3.1 Global Recombinant Erythropoietin Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Recombinant Erythropoietin Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Recombinant Erythropoietin Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Recombinant Erythropoietin Drugs Manufacturer Market Share
3.4.2 Top 6 Recombinant Erythropoietin Drugs Manufacturer Market Share
3.5 Global Recombinant Erythropoietin Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Recombinant Erythropoietin Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Recombinant Erythropoietin Drugs Market Size by Region
4.1.1 Global Recombinant Erythropoietin Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Recombinant Erythropoietin Drugs Revenue by Region (2016-2026)
4.2 North America Recombinant Erythropoietin Drugs Revenue (2016-2026)
4.3 Europe Recombinant Erythropoietin Drugs Revenue (2016-2026)
4.4 Asia-Pacific Recombinant Erythropoietin Drugs Revenue (2016-2026)
4.5 South America Recombinant Erythropoietin Drugs Revenue (2016-2026)
4.6 Middle East and Africa Recombinant Erythropoietin Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Recombinant Erythropoietin Drugs Sales in Volume by Type (2016-2026)
5.2 Global Recombinant Erythropoietin Drugs Revenue by Type (2016-2026)
5.3 Global Recombinant Erythropoietin Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Recombinant Erythropoietin Drugs Sales in Volume by Application (2016-2026)
6.2 Global Recombinant Erythropoietin Drugs Revenue by Application (2016-2026)
6.3 Global Recombinant Erythropoietin Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Recombinant Erythropoietin Drugs Sales by Type (2016-2026)
7.2 North America Recombinant Erythropoietin Drugs Sales by Application (2016-2026)
7.3 North America Recombinant Erythropoietin Drugs Market Size by Country
7.3.1 North America Recombinant Erythropoietin Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Recombinant Erythropoietin Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Recombinant Erythropoietin Drugs Sales by Type (2016-2026)
8.2 Europe Recombinant Erythropoietin Drugs Sales by Application (2016-2026)
8.3 Europe Recombinant Erythropoietin Drugs Market Size by Country
8.3.1 Europe Recombinant Erythropoietin Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Recombinant Erythropoietin Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Recombinant Erythropoietin Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Recombinant Erythropoietin Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Recombinant Erythropoietin Drugs Market Size by Region
9.3.1 Asia-Pacific Recombinant Erythropoietin Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Recombinant Erythropoietin Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Recombinant Erythropoietin Drugs Sales by Type (2016-2026)
10.2 South America Recombinant Erythropoietin Drugs Sales by Application (2016-2026)
10.3 South America Recombinant Erythropoietin Drugs Market Size by Country
10.3.1 South America Recombinant Erythropoietin Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Recombinant Erythropoietin Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Recombinant Erythropoietin Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Recombinant Erythropoietin Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Recombinant Erythropoietin Drugs Market Size by Country
11.3.1 Middle East & Africa Recombinant Erythropoietin Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Recombinant Erythropoietin Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Recombinant Erythropoietin Drugs Typical Distributors
12.3 Recombinant Erythropoietin Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Recombinant Erythropoietin Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Recombinant Erythropoietin Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Amgen Basic Information, Manufacturing Base and Competitors
Table 4. Amgen Major Business
Table 5. Amgen Recombinant Erythropoietin Drugs Product and Services
Table 6. Amgen Recombinant Erythropoietin Drugs Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 8. Johnson & Johnson Major Business
Table 9. Johnson & Johnson Recombinant Erythropoietin Drugs Product and Services
Table 10. Johnson & Johnson Recombinant Erythropoietin Drugs Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Kyowa Hakko Kirin Basic Information, Manufacturing Base and Competitors
Table 12. Kyowa Hakko Kirin Major Business
Table 13. Kyowa Hakko Kirin Recombinant Erythropoietin Drugs Product and Services
Table 14. Kyowa Hakko Kirin Recombinant Erythropoietin Drugs Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Roche Basic Information, Manufacturing Base and Competitors
Table 16. Roche Major Business
Table 17. Roche Recombinant Erythropoietin Drugs Product and Services
Table 18. Roche Recombinant Erythropoietin Drugs Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. 3SBio Group Basic Information, Manufacturing Base and Competitors
Table 20. 3SBio Group Major Business
Table 21. 3SBio Group Recombinant Erythropoietin Drugs Product and Services
Table 22. 3SBio Group Recombinant Erythropoietin Drugs Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Celltrion, Inc Basic Information, Manufacturing Base and Competitors
Table 24. Celltrion, Inc Major Business
Table 25. Celltrion, Inc Recombinant Erythropoietin Drugs Product and Services
Table 26. Celltrion, Inc Recombinant Erythropoietin Drugs Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 28. Teva Pharmaceutical Industries Ltd Major Business
Table 29. Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Product and Services
Table 30. Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 32. F. Hoffmann-La Roche Ltd Major Business
Table 33. F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Drugs Product and Services
Table 34. F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Drugs Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. LG Life Sciences Ltd Basic Information, Manufacturing Base and Competitors
Table 36. LG Life Sciences Ltd Major Business
Table 37. LG Life Sciences Ltd Recombinant Erythropoietin Drugs Product and Services
Table 38. LG Life Sciences Ltd Recombinant Erythropoietin Drugs Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Biocon Limited Basic Information, Manufacturing Base and Competitors
Table 40. Biocon Limited Major Business
Table 41. Biocon Limited Recombinant Erythropoietin Drugs Product and Services
Table 42. Biocon Limited Recombinant Erythropoietin Drugs Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Intas Pharmaceuticals Ltd Basic Information, Manufacturing Base and Competitors
Table 44. Intas Pharmaceuticals Ltd Major Business
Table 45. Intas Pharmaceuticals Ltd Recombinant Erythropoietin Drugs Product and Services
Table 46. Intas Pharmaceuticals Ltd Recombinant Erythropoietin Drugs Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Sun Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 48. Sun Pharmaceutical Industries Ltd Major Business
Table 49. Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Product and Services
Table 50. Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Dr. Reddy's Laboratories Ltd Basic Information, Manufacturing Base and Competitors
Table 52. Dr. Reddy's Laboratories Ltd Major Business
Table 53. Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Drugs Product and Services
Table 54. Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Drugs Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Global Recombinant Erythropoietin Drugs Sales by Manufacturer (2019-2021e) & (KG)
Table 56. Global Recombinant Erythropoietin Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 57. Market Position of Manufacturers in Recombinant Erythropoietin Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 58. Global Recombinant Erythropoietin Drugs Production Capacity by Company, (KG): 2020 VS 2021
Table 59. Head Office and Recombinant Erythropoietin Drugs Production Site of Key Manufacturer
Table 60. Global Recombinant Erythropoietin Drugs Sales by Region (2016-2021e) & (KG)
Table 61. Global Recombinant Erythropoietin Drugs Sales by Region (2021-2026) & (KG)
Table 62. Global Recombinant Erythropoietin Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 63. Global Recombinant Erythropoietin Drugs Revenue by Region (2021-2026) & (USD Million)
Table 64. Global Recombinant Erythropoietin Drugs Sales by Type (2016-2021e) & (KG)
Table 65. Global Recombinant Erythropoietin Drugs Sales by Type (2021-2026) & (KG)
Table 66. Global Recombinant Erythropoietin Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 67. Global Recombinant Erythropoietin Drugs Revenue by Type (2021-2026) & (USD Million)
Table 68. Global Recombinant Erythropoietin Drugs Price by Type (2016-2021e) & (USD/g)
Table 69. Global Recombinant Erythropoietin Drugs Price by Type (2021-2026) & (USD/g)
Table 70. Global Recombinant Erythropoietin Drugs Sales by Application (2016-2021e) & (KG)
Table 71. Global Recombinant Erythropoietin Drugs Sales by Application (2021-2026) & (KG)
Table 72. Global Recombinant Erythropoietin Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 73. Global Recombinant Erythropoietin Drugs Revenue by Application (2021-2026) & (USD Million)
Table 74. Global Recombinant Erythropoietin Drugs Price by Application (2016-2021e) & (USD/g)
Table 75. Global Recombinant Erythropoietin Drugs Price by Application (2021-2026) & (USD/g)
Table 76. North America Recombinant Erythropoietin Drugs Sales by Country (2016-2021e) & (KG)
Table 77. North America Recombinant Erythropoietin Drugs Sales by Country (2021-2026) & (KG)
Table 78. North America Recombinant Erythropoietin Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 79. North America Recombinant Erythropoietin Drugs Revenue by Country (2021-2026) & (USD Million)
Table 80. North America Recombinant Erythropoietin Drugs Sales by Type (2016-2021e) & (KG)
Table 81. North America Recombinant Erythropoietin Drugs Sales by Type (2021-2026) & (KG)
Table 82. North America Recombinant Erythropoietin Drugs Sales by Application (2016-2021e) & (KG)
Table 83. North America Recombinant Erythropoietin Drugs Sales by Application (2021-2026) & (KG)
Table 84. Europe Recombinant Erythropoietin Drugs Sales by Country (2016-2021e) & (KG)
Table 85. Europe Recombinant Erythropoietin Drugs Sales by Country (2021-2026) & (KG)
Table 86. Europe Recombinant Erythropoietin Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 87. Europe Recombinant Erythropoietin Drugs Revenue by Country (2021-2026) & (USD Million)
Table 88. Europe Recombinant Erythropoietin Drugs Sales by Type (2016-2021e) & (KG)
Table 89. Europe Recombinant Erythropoietin Drugs Sales by Type (2021-2026) & (KG)
Table 90. Europe Recombinant Erythropoietin Drugs Sales by Application (2016-2021e) & (KG)
Table 91. Europe Recombinant Erythropoietin Drugs Sales by Application (2021-2026) & (KG)
Table 92. Asia-Pacific Recombinant Erythropoietin Drugs Sales by Region (2016-2021e) & (KG)
Table 93. Asia-Pacific Recombinant Erythropoietin Drugs Sales by Region (2021-2026) & (KG)
Table 94. Asia-Pacific Recombinant Erythropoietin Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 95. Asia-Pacific Recombinant Erythropoietin Drugs Revenue by Region (2021-2026) & (USD Million)
Table 96. Asia-Pacific Recombinant Erythropoietin Drugs Sales by Type (2016-2021e) & (KG)
Table 97. Asia-Pacific Recombinant Erythropoietin Drugs Sales by Type (2021-2026) & (KG)
Table 98. Asia-Pacific Recombinant Erythropoietin Drugs Sales by Application (2016-2021e) & (KG)
Table 99. Asia-Pacific Recombinant Erythropoietin Drugs Sales by Application (2021-2026) & (KG)
Table 100. South America Recombinant Erythropoietin Drugs Sales by Country (2016-2021e) & (KG)
Table 101. South America Recombinant Erythropoietin Drugs Sales by Country (2021-2026) & (KG)
Table 102. South America Recombinant Erythropoietin Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 103. South America Recombinant Erythropoietin Drugs Revenue by Country (2021-2026) & (USD Million)
Table 104. South America Recombinant Erythropoietin Drugs Sales by Type (2016-2021e) & (KG)
Table 105. South America Recombinant Erythropoietin Drugs Sales by Type (2021-2026) & (KG)
Table 106. South America Recombinant Erythropoietin Drugs Sales by Application (2016-2021e) & (KG)
Table 107. South America Recombinant Erythropoietin Drugs Sales by Application (2021-2026) & (KG)
Table 108. Middle East & Africa Recombinant Erythropoietin Drugs Sales by Country (2016-2021e) & (KG)
Table 109. Middle East & Africa Recombinant Erythropoietin Drugs Sales by Country (2021-2026) & (KG)
Table 110. Middle East & Africa Recombinant Erythropoietin Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 111. Middle East & Africa Recombinant Erythropoietin Drugs Revenue by Country (2021-2026) & (USD Million)
Table 112. Middle East & Africa Recombinant Erythropoietin Drugs Sales by Type (2016-2021e) & (KG)
Table 113. Middle East & Africa Recombinant Erythropoietin Drugs Sales by Type (2021-2026) & (KG)
Table 114. Middle East & Africa Recombinant Erythropoietin Drugs Sales by Application (2016-2021e) & (KG)
Table 115. Middle East & Africa Recombinant Erythropoietin Drugs Sales by Application (2021-2026) & (KG)
Table 116. Direct Channel Pros & Cons
Table 117. Indirect Channel Pros & Cons
Table 118. Recombinant Erythropoietin Drugs Typical Distributors
Table 119. Recombinant Erythropoietin Drugs Typical Customers
List of Figures
Figure 1. Recombinant Erythropoietin Drugs Picture
Figure 2. Global Recombinant Erythropoietin Drugs Sales Market Share by Type in 2020
Figure 3. rhEPO
Figure 4. Erythropoiesis-Stimulating Agents (ESA)
Figure 5. Global Recombinant Erythropoietin Drugs Sales Market Share by Application in 2020
Figure 6. Chronic Kidney Disease
Figure 7. Cancer Related Anemia
Figure 8. Others
Figure 9. Global Recombinant Erythropoietin Drugs Market Size, (USD Million) & (KG): 2020 VS 2021 VS 2026
Figure 10. Global Recombinant Erythropoietin Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Recombinant Erythropoietin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Recombinant Erythropoietin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Recombinant Erythropoietin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Recombinant Erythropoietin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Recombinant Erythropoietin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Recombinant Erythropoietin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Recombinant Erythropoietin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Recombinant Erythropoietin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Recombinant Erythropoietin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Recombinant Erythropoietin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Recombinant Erythropoietin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Recombinant Erythropoietin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Recombinant Erythropoietin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Recombinant Erythropoietin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Recombinant Erythropoietin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Recombinant Erythropoietin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Recombinant Erythropoietin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Recombinant Erythropoietin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Recombinant Erythropoietin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Recombinant Erythropoietin Drugs Sales (2016-2026) & (KG)
Figure 31. Global Recombinant Erythropoietin Drugs Production Capacity (2016-2026) & (KG)
Figure 32. Global Recombinant Erythropoietin Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Recombinant Erythropoietin Drugs Market Drivers
Figure 34. Recombinant Erythropoietin Drugs Market Restraints
Figure 35. Recombinant Erythropoietin Drugs Market Trends
Figure 36. Global Recombinant Erythropoietin Drugs Sales Market Share by Manufacturer in 2020
Figure 37. Global Recombinant Erythropoietin Drugs Revenue Market Share by Manufacturer in 2020
Figure 38. Recombinant Erythropoietin Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Recombinant Erythropoietin Drugs Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Recombinant Erythropoietin Drugs Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Recombinant Erythropoietin Drugs Sales Market Share by Region (2016-2026)
Figure 42. Global Recombinant Erythropoietin Drugs Revenue Market Share by Region (2016-2026)
Figure 43. North America Recombinant Erythropoietin Drugs Revenue (2016-2026) & (USD Million)
Figure 44. Europe Recombinant Erythropoietin Drugs Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Recombinant Erythropoietin Drugs Revenue (2016-2026) & (USD Million)
Figure 46. South America Recombinant Erythropoietin Drugs Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Recombinant Erythropoietin Drugs Revenue (2016-2026) & (USD Million)
Figure 48. Global Recombinant Erythropoietin Drugs Sales Market Share by Type (2016-2026)
Figure 49. Global Recombinant Erythropoietin Drugs Revenue Market Share by Type (2016-2026)
Figure 50. Global Recombinant Erythropoietin Drugs Price by Type (2016-2026) & (USD/g)
Figure 51. Global Recombinant Erythropoietin Drugs Sales Market Share by Application (2016-2026)
Figure 52. Global Recombinant Erythropoietin Drugs Revenue Market Share by Application (2016-2026)
Figure 53. Global Recombinant Erythropoietin Drugs Price by Application (2016-2026) & (USD/g)
Figure 54. North America Recombinant Erythropoietin Drugs Sales Market Share by Country (2016-2026)
Figure 55. North America Recombinant Erythropoietin Drugs Revenue Market Share by Country (2016-2026)
Figure 56. North America Recombinant Erythropoietin Drugs Sales Market Share by Type (2016-2026)
Figure 57. North America Recombinant Erythropoietin Drugs Sales Market Share by Application (2016-2026)
Figure 58. Europe Recombinant Erythropoietin Drugs Sales Market Share by Country (2016-2026)
Figure 59. Europe Recombinant Erythropoietin Drugs Revenue Market Share by Country (2016-2026)
Figure 60. Europe Recombinant Erythropoietin Drugs Sales Market Share by Type (2016-2026)
Figure 61. Europe Recombinant Erythropoietin Drugs Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Recombinant Erythropoietin Drugs Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Recombinant Erythropoietin Drugs Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Recombinant Erythropoietin Drugs Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Recombinant Erythropoietin Drugs Sales Market Share by Application (2016-2026)
Figure 66. South America Recombinant Erythropoietin Drugs Sales Market Share by Country (2016-2026)
Figure 67. South America Recombinant Erythropoietin Drugs Revenue Market Share by Country (2016-2026)
Figure 68. South America Recombinant Erythropoietin Drugs Sales Market Share by Type (2016-2026)
Figure 69. South America Recombinant Erythropoietin Drugs Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Recombinant Erythropoietin Drugs Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Recombinant Erythropoietin Drugs Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Recombinant Erythropoietin Drugs Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Recombinant Erythropoietin Drugs Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source
エリスロポエチン(EPO)薬の世界市場2018-2025 EPO is a naturally occurring hormone produced by cells in the kidneys that regulate the production of red blood cells in bone marrow.Increasing incidence of chronic diseases such as end-stage renal diseases, cancer, and HIV is expected to accelerate demand for EPO-stimulating agents as these disease…- 世界の遺伝子組換え型ヒト顆粒球コロニー刺激因子市場 2021：企業別、地域別、種類・用途別 The Recombinant Human Granulocyte Colony-Stimulating market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain op…
- 世界の遺伝子組換え型サイトカイン治療薬市場 2021：企業別、地域別、種類・用途別 The Recombinant Cytokines Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regu…
- 慢性腎疾患（CKD）薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Chronic Kidney Disease (CKD) Drugs are drugs for Chronic kidney disease, which also called chronic kidney failure, describes the gradual loss of kidney function. Scope of the Report: This report focuses on the Chronic Kidney Disease (CKD) Drugs in global market, especially in North America, Europe a…
- 組み換え凝固因子の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Recombinant coagulation factors are plasma derived counterparts used to treat infection from viruses such as hepatitis C and the human immunodeficiency virus. In addition, recombinant coagulation factors have low risk for transmission of infectious agents. Scope of the Report: This report studies th…